Prof. Binbin Cui 崔滨滨
Chief Physician, Professor
Department of Colorectal Surgery, Harbin Medical University Cancer Hospital, Harbin
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical treatment of colorectal, gastric, breast, liver, and pancreatic tumors. Expertise in extended radical resection for rectal cancer, sphincter-preserving surgery, and laparoscopic minimally invasive procedures for colorectal cancer.
Dr. Cui is Chief Physician, Professor, and Director of Colorectal Surgery at Harbin Medical University Cancer Hospital. Dr. Cui earned a PhD from Harbin Medical University (2004) and completed advanced training at Beijing 301 Hospital and Shanghai Ruijin Hospital Minimally Invasive Center. Research focuses on functional rectal cancer resection and laparoscopic applications. Dr. Cui has received provincial science and technology awards and published over ten papers.
Professional roles
- Vice Chair, Colorectal Cancer Professional Committee, Heilongjiang Anti-Cancer Association
- Vice Chair, Biotherapy Committee, Heilongjiang Province
- Member, Laparoscopic Surgery Professional Committee, Heilongjiang Medical Association
- Standing Editorial Board Member, Chinese Journal of Practical Medicine
Name order: in Chinese the family name comes first (Cui Binbin). Papers usually list the name as Binbin Cui or Cui B.
Selected publications
37 papers on PubMed matched by name and affiliation; 21 as first or senior author since 2016. Most recent first- or senior-author papers:
- NPJ Precis Oncol, 2026 (senior author): Neoadjuvant FOLFOXIRI chemotherapy with or without camrelizumab in the treatment of locally advanced rectal cancer: a retrospective cohort study. PubMed 41935188
- Cell Death Dis, 2025 (senior author): CNOT7 facilitates radiation resistance in colorectal cancer through TRIM21/XRCC6-mediated non-homologous end joining repair. PubMed 41249119
- Radiol Oncol, 2025 (senior author): Identification of hub genes predicting sensitivity to neoadjuvant chemoradiation in locally advanced rectal cancer. PubMed 40770782
- J Gastrointest Oncol, 2025 (senior author): Prognostic role of tertiary lymphatic structures and their modulation by adjuvant FOLFOX in stage III colon cancer: a retrospective cohort study. PubMed 40386587
- World J Surg Oncol, 2025 (senior author): Correlation analysis of tertiary lymphoid structure parameters with the prognosis of patients with locally advanced rectal cancer after neoadjuvant chemotherapy: a retrospective study. PubMed 40205382
- Curr Med Chem, 2025 (senior author): Development of a Mitochondrial Membrane Permeability Transition Prognosis System in Colon Adenocarcinoma: Risk Stratification and Therapeutic Target Identification. PubMed 39377410
- Front Oncol, 2023 (senior author): Cuproplasia characterization in colon cancer assists to predict prognosis and immunotherapeutic response. PubMed 37007132
- Front Bioeng Biotechnol, 2022 (senior author): A Novel Quantification System Combining iTRAQ Technology and Multi-Omics Assessment to Predict Prognosis and Immunotherapy Efficacy in Colon Cancer. PubMed 35445008
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion